Search Legislation

The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019

 Help about what version

What Version

 Help about opening options

Opening Options

Status:

This is the original version (as it was originally made).

Insertion of regulation 57 (functions in relation to good clinical practice)

This section has no associated Explanatory Memorandum

23.  After regulation 56, insert—

Functions in relation to good clinical practice

57.(1) Regulations may—

(a)amend the conditions and principles of good clinical practice to take account of technical and scientific progress;

(b)specify requirements for documentation relating to a clinical trial which constitute the master file on the trial at the time the file is archived;

(c)amend or revoke the requirements of regulation 31A relating to the content of the trial master file; and

(d)require guidance published under regulation 58 to be taken into account when interpreting any enactment or other requirement to which the guidance relates.

(2) Any power to make regulations under paragraph (1)—

(a)is exercisable—

(i)in respect of Northern Ireland only, by the Minister of Health in Northern Ireland by statutory rule for the purposes of the Statutory Rules (Northern Ireland) Order 1979(1);

(ii)in respect of any part of the United Kingdom, by the Secretary of State by statutory instrument;

(b)in respect of Northern Ireland may be exercised by—

(i)the Minister of Health acting alone; or

(ii)the Secretary of State acting with the agreement of the Minister of Health;

(c)includes power to make—

(i)different provision for different purposes or different areas;

(ii)consequential, supplementary, incidental, transitional, transitory or saving provisions, including consequential amendments to these Regulations.

(3) Regulations under paragraph (1) are—

(a)in the case of a statutory instrument made by the Secretary of State, subject to annulment in pursuance of a resolution of either House of Parliament;

(b)in the case of statutory rules made by the Minister of Health in Northern Ireland, subject to negative resolution within the meaning of section 41(6) of the Interpretation Act (Northern Ireland) 1954(2).

Detailed guidance

58.  The licensing authority may publish guidance on—

(a)the application format and documentation to be submitted in an application for an ethics committee opinion, in particular regarding the information that is given to subjects, and on the appropriate safeguards for the protection of personal data;

(b)the format and contents of a request for authorisation of a clinical trial, as well as the documentation to be submitted to support that request, on the quality and manufacture of the investigational medicinal product, any toxicological and pharmacological tests, the protocol and clinical information on the investigational medicinal product including the investigator’s brochure;

(c)the presentation and content of any proposed substantial amendment to the clinical trial authorisation insofar as it relates to the protocol;

(d)the declaration of the end of the clinical trial;

(e)the collection, verification and presentation of adverse event or adverse reaction reports, together with decoding procedures for unexpected serious adverse reactions;

(f)the content of essential documents forming part of the trial master file;

(g)the elements to be taken into account when evaluating investigational medicinal products for the purpose of regulation 43(2)..

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Memorandum

Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Impact Assessments

Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:

  • Why the government is proposing to intervene;
  • The main options the government is considering, and which one is preferred;
  • How and to what extent new policies may impact on them; and,
  • The estimated costs and benefits of proposed measures.
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources